Innova Captab Ltd Q2 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/as-bf4d6a56c9b954d188d40e2f.pdf

Key Takeaways


Jammu Facility Ramp-Up

Vinay Lohariwala: "So whereas the cost of equipment is increasing, they are giving a better quality assurance and operational excellency as well. So that's the optimization in both the front. With the regulatory compliances, the cost of equipment, cost of plant is increasing. So that is tending towards three times of the FATR after four or five years."

Margin Dynamics & API Pass-Through

Lokesh Bhasin: "So as I submitted, it's a complex mix, and depending upon how the pricing moved from order to order, that is then it has impacted our overall margin profile, both in slightly in domestic as well as in exports also."

Business Model & Return Profile

Lokesh Bhasin: "So Abhi, if you see that the business model with the three times of the FATR and 15%, 16% of EBITDA will also result into 16%, 17% of ROE with the 90 days worth capital. It's a simple math."

CDMO & Branded Generics Performance


Guidance & Commitments

CommitmentSpecificsTimeline
Jammu quarterly revenue₹140–150 crores per quarterNext two quarters
Jammu annual revenueCross ₹500 croresThis fiscal year
Volume growth20% annuallyNext two years (through FY29)
EBITDA margin rangeWithin plus/minus 2% of current levelsOngoing; improvement gradual and organic
Margin normalizationMargins move back to normalized position if API prices stabilizeConditional on API price stability
Jammu facility capacityReach ₹1,200–1,300 croresApproximately two years
Post-FY29 growth triggerDeploy ~₹400 crore treasury into greenfield or inorganic acquisitionTo be communicated when tangible conclusion reached

Key Metrics

MetricQ2 FY27
Consolidated revenue₹496.3 cr, +30.5% YoY
H1 FY27 consolidated revenue₹967.2 cr, +32.1% YoY
EBITDA₹72.4 cr, +29% YoY
EBITDA margin14.6%
H1 FY27 EBITDA₹147.5 cr, +31% YoY
H1 FY27 EBITDA margin15.3%
PAT₹42.4 cr, +43% YoY
H1 FY27 PAT₹86.5 cr, +43% YoY
CDMO revenue₹345.2 cr, +30% YoY; contributed nearly 70% of total revenue
Branded generic revenue₹151.1 cr, +32% YoY
Exports share of revenue29% of Q2 revenue, 30% of H1 revenue
Jammu facility revenue~₹105 cr quarterly, annualized run-rate ~₹450 cr
Jammu facility capacity utilization22%–24% on an annualized basis
Jammu facility EBITDA~₹2 cr to ₹2.25 cr absolute
Consolidated gross margin impact from API cost escalation2.8% difference; standalone impact 0.8%
Ex-Jammu organic growth rate10%–12%
Volume growth guidance20% maintained for coming years
Jammu facility FY27 annual revenue expectation₹450 cr to ₹500+ cr
Jammu facility next two quarters revenue expectation₹125 cr to ₹150 cr per quarter
Consolidated FATR ex-Jammu~4.0x
FATR ex-Sharon (standalone)4.5x plus
IPM market volume growth6%–7%
Treasury available for reinvestment~₹400 cr